These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 12605394
1. Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency. Cecyn KZ, Lee J, Oguro T, Petrilli AS, Bordin JO. Am J Hematol; 2003 Mar; 72(3):209-11. PubMed ID: 12605394 [Abstract] [Full Text] [Related]
2. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, Bacci G, Craft AW, Adamson PC. Cancer; 2004 May 15; 100(10):2222-32. PubMed ID: 15139068 [Abstract] [Full Text] [Related]
3. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy. Bacci G, Ferrari S, Longhi A, Forni C, Loro L, Beghelli C, Tremosini M, Versari M. Oncol Rep; 2003 May 15; 10(4):851-7. PubMed ID: 12792734 [Abstract] [Full Text] [Related]
4. Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism. Müller J, Kralovánszky J, Adleff V, Pap E, Németh K, Komlósi V, Kovács G. Anticancer Res; 2008 May 15; 28(5B):3051-4. PubMed ID: 19031955 [Abstract] [Full Text] [Related]
5. [Toxicosis of high-dose methotrexate (HD-MTX) for osteosarcoma, cured with treatment by leucovorin (LV) rescue and hemoperfusion--a case report]. Kobayashi H, Morita T, Hirata Y, Kato T, Okada Y, Sato T. Gan To Kagaku Ryoho; 2000 Mar 15; 27(3):475-8. PubMed ID: 10740644 [Abstract] [Full Text] [Related]
6. Late-onset delayed excretion of methotrexate. Pauley JL, Panetta JC, Schmidt J, Kornegay N, Relling MV, Pui CH. Cancer Chemother Pharmacol; 2004 Aug 15; 54(2):146-52. PubMed ID: 15148625 [Abstract] [Full Text] [Related]
7. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance. Joannon P, Oviedo I, Campbell M, Tordecilla J. Pediatr Blood Cancer; 2004 Jul 15; 43(1):17-22. PubMed ID: 15170885 [Abstract] [Full Text] [Related]
8. Early recognition of renal toxicity of high-dose methotrexate therapy: a case report. Nowicki TS, Bjornard K, Kudlowitz D, Sandoval C, Jayabose S. J Pediatr Hematol Oncol; 2008 Dec 15; 30(12):950-2. PubMed ID: 19131789 [Abstract] [Full Text] [Related]
9. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue. Zelcer S, Kellick M, Wexler LH, Gorlick R, Meyers PA. Pediatr Blood Cancer; 2008 Jun 15; 50(6):1176-80. PubMed ID: 18266225 [Abstract] [Full Text] [Related]
10. Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase. Vilay AM, Mueller BA, Haines H, Alten JA, Askenazi DJ. Pharmacotherapy; 2010 Jan 15; 30(1):111. PubMed ID: 20030480 [Abstract] [Full Text] [Related]
11. [The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma]. Graf N, Jost W, Müller J, Keller HE, Sitzmann FC. Klin Padiatr; 1990 Jan 15; 202(5):340-6. PubMed ID: 2214594 [Abstract] [Full Text] [Related]
12. [Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate]. Ferrari S, Orlandi M, Avella M, Caldora P, Ferraro A, Ravazzolo G, Bacci G. Minerva Med; 1992 May 15; 83(5):289-93. PubMed ID: 1589134 [Abstract] [Full Text] [Related]
13. [Carboxypeptidase-G2 administration after high-dose methotrexate. Treatment and drug interactions]. Cózar Olmo JA, Martínez Colmenero C, Peláez Pleguezuelos I, Leiva Gea I, López García AB, de la Cruz Moreno J. An Pediatr (Barc); 2009 Sep 15; 71(3):230-4. PubMed ID: 19617010 [Abstract] [Full Text] [Related]
14. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity. Widemann BC, Hetherington ML, Murphy RF, Balis FM, Adamson PC. Cancer; 1995 Aug 01; 76(3):521-6. PubMed ID: 8625136 [Abstract] [Full Text] [Related]
15. Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma. Mir O, Ropert S, Babinet A, Alexandre J, Larousserie F, Durand JP, Enkaoua E, Anract P, Goldwasser F. Cancer Chemother Pharmacol; 2010 Nov 01; 66(6):1059-63. PubMed ID: 20155268 [Abstract] [Full Text] [Related]
16. [Managing methotrexate toxicity: a case report]. Fernández Megía MJ, Alós Almiñana M, Terol Castera MJ. Farm Hosp; 2004 Nov 01; 28(5):371-4. PubMed ID: 15504095 [Abstract] [Full Text] [Related]
17. [The need for a better definition of therapeutic indications of carboxypeptidase in delayed elimination of methotrexate]. Blasco H, Silly S, Tournamille JF, Gyan E, Sénécal D, André V, Colombat P, Le Guellec C. Therapie; 2008 Nov 01; 63(1):19-28. PubMed ID: 18387272 [Abstract] [Full Text] [Related]
18. [Management recommendations in patients with methotrexate intoxication]. Schellens JH, Beijnen JH. Ned Tijdschr Geneeskd; 2007 Feb 10; 151(6):337-41. PubMed ID: 17352296 [Abstract] [Full Text] [Related]
19. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma. Colom H, Farré R, Soy D, Peraire C, Cendros JM, Pardo N, Torrent M, Domenech J, Mangues MA. Ther Drug Monit; 2009 Feb 10; 31(1):76-85. PubMed ID: 19077931 [Abstract] [Full Text] [Related]
20. Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism. Turello R, Rentsch K, Di Paolo E, Popovic MB. Pediatr Blood Cancer; 2008 Jan 10; 50(1):154-6. PubMed ID: 17387702 [Abstract] [Full Text] [Related] Page: [Next] [New Search]